Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Symbios mineralized cortical-cancellous granule mix + Symbios OsteoShield Collagen Resorbable Membrane
- Development stage
- Unknown
- Lead developer
- Dentsply Sirona
- Administration
- Topical
01
Overview
Symbios mineralized cortical-cancellous granule mix + Symbios OsteoShield Collagen Resorbable Membrane is a combination of dental biomaterials used for alveolar ridge preservation and guided bone regeneration (GBR). The allograft component consists of a mixture of mineralized cortical and cancellous bone granules derived from human donors, providing an osteoconductive scaffold that supports the migration and attachment of osteogenic cells for new bone formation. The Symbios OsteoShield component is a resorbable membrane made from highly purified porcine Type I collagen, designed to act as a biological barrier that prevents fast-growing soft tissue from infiltrating the bone graft site, thereby facilitating undisturbed bone healing. This specific combination was evaluated by the University of North Carolina, Chapel Hill, in comparative clinical studies to assess its efficacy in maintaining alveolar ridge volume following tooth extraction to support future dental implant placement.
- Other names
- Allograft, MembraneSymbios Allograft + Symbios OsteoShield
02
Targets
COL1 (Collagen type I)
Beyond the preview
Go deeper on Symbios mineralized cortical-cancellous granule mix + Symbios OsteoShield Collagen Resorbable Membrane.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Symbios mineralized cortical-cancellous granule mix + Symbios OsteoShield Collagen Resorbable Membrane.